Health Sciences Authority names new CEO

Raymond Chua Swee Boon will succeed Mimi Choong May Ling in the role.

The Health Sciences Authority (HSA) has appointed Raymond Chua Swee Boon as CEO-Designate, before officially assuming the role on 13 December.

He will succeed Mimi Choong May Ling, who is set to retire from public service later this year.

Chua is currently the deputy director-general of Health (Health Regulation) at the Ministry of Health and will continue to hold this position alongside his role as CEO.

Before his appointment at the ministry, Chua was the group director of the Health Products Regulation Group at HSA. He holds a Bachelor of Medicine and Bachelor of Surgery from the NUS Yong Loo Lin School of Medicine.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia